What’s Propelling Precipio, Inc. (PRPO) to Reach Yearly Low?

July 16, 2018 - By Vernon Prom

The stock of Precipio, Inc. (NASDAQ:PRPO) hit a new 52-week low and has $0.32 target or 7.00 % below today’s $0.34 share price. The 5 months bearish chart indicates high risk for the $6.96 million company. The 1-year low was reported on Jul, 16 by Barchart.com. If the $0.32 price target is reached, the company will be worth $487,130 less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock.

The stock increased 2.22% or $0.01 during the last trading session, reaching $0.34. About 159,880 shares traded. Precipio, Inc. (NASDAQ:PRPO) has declined 93.08% since July 16, 2017 and is downtrending. It has underperformed by 105.65% the S&P500.

More news for Precipio, Inc. (NASDAQ:PRPO) were recently published by: Globenewswire.com, which released: “Precipio Updates Commercial Pipeline for its ICE-COLD PCRâ„¢ Liquid Biopsy Technology” on June 19, 2018. Nasdaq.com‘s article titled: “Precipio and Nucleai Partner to Develop Artificial Intelligence-Powered Hemepath Solution” and published on June 26, 2018 is yet another important article.

Precipio, Inc. provides diagnostic information to physicians and their patients worldwide. The company has market cap of $6.96 million. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.